How can we improve the patient-doctor encounter supported through tech? Since qualifying as a GP in 2014 I have been drawn to this deceptively simple question & dedicated much of my time to starting to formulate a response.

Clinical work as a GP partner has been complemented by a diverse range of roles and collaboration spanning policy, digital & innovation incorporating Royal Colleges & multinational corporates, start-ups & NHS Digital, Oxford University, The Kings Fund, European Patients’ Forum & Digital Health Europe.

I’ve gained insights into how we can make use of the precious time together better, equipping clinicians and patients alike with the information & tools they need. This leads naturally to transformative change improving both quality and efficiency.

I have been grateful for opportunities to distil some of my experiences in Covid times and share these in international presentations, medical and national media.

As clinicians, we may see medications as tools with which we can help people shape their current and future health; whether it be antibiotics for a chest infection now or blood pressure medication to reduce their risk of a stroke in the future. Prescribing a medication is only a small part of the process. Reaching a shared understanding of the role, risk, benefits, treatment length, anticipated side effects of any given medication will frame & influence the impact of our treatment decisions. I’m excited to explore this more as part of the UAG discussion.